Full Text View
Tabular View
No Study Results Posted
Related Studies
PK and Safety Study of Paclitaxel Injection Concentrate for Nano-dispersion Administered Weekly
This study is currently recruiting participants.
Verified January 2013 by Sun Pharma Advanced Research Company Limited
Study NCT01305512   Information provided by Sun Pharma Advanced Research Company Limited

First Received on February 24, 2011.   Last Updated on January 18, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumor in Advanced Stage
Additional drug interventions recognized in this trial
Paclitaxel
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Sun Pharma Advanced Research Company Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services